The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leighton, J.
Right arrow Articles by Adorini, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leighton, J.
Right arrow Articles by Adorini, L.

The Journal of Immunology, Vol 147, Issue 1 198-204, Copyright © 1991 by American Association of Immunologists


ARTICLES

Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II- restricted T cells

J Leighton, A Sette, J Sidney, E Appella, C Ehrhardt, S Fuchs and L Adorini
Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.

We have analyzed the interaction of the hen egg-white lysozyme (HEL) peptide 107-116 with the MHC class II molecule I-Ek, using truncated and single residue substitution analogues to measure activation of I-Ek- restricted, 107-116-specific T cell hybridomas and competition for Ag presentation by I-Ek molecules. These results have been compared with previous findings on the interaction of the same peptide with the I-Ed molecule. Stimulation of T cell hybridomas by truncated peptides defines the sequence 108-116 as the minimum epitope necessary for activation of both I-Ek- and I-Ed-restricted T cell hybridomas. Substitution analysis pinpoints three residues (V109, A110, and K116) in the sequence 108-116 as being critical for binding to I-Ek molecules and demonstrates the involvement of most other residues in recognition by T cells. Results previously obtained for binding of HEL 107-116 to I- Ed molecules indicated that peptide residues R112, R114, and K116 were critical for interaction with I-Ed. Comparison of these results indicates a difference in the likely MHC contact residues between the HEL sequence 108-116 and I-Ed or I-Ek molecules, suggesting that the same HEL peptide assumes a different conformation in the binding site of these two MHC molecules. This in turn affects residues interacting with the specific T cell receptor. According to the hypothetical tridimensional structure predicted for class II molecules, the difference in MHC contact residues observed within the sequence 108-116 can be related to polymorphic amino acids in the binding site of I-Ek and I-Ed molecules. A search through published binding data for a common pattern in this and other I-Ek-binding peptides has permitted us to derive a possible motif for predicting peptide binding to I-Ek molecules. This putative motif was tested by determining binding to I- Ek of an unbiased panel of about 150 synthetic peptides. Binding data indeed demonstrate the presence of this motif in the majority of good binders to I-Ek molecules.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
K. M. Williams and E. C. Bigley III
Identification of an I-Ed-Restricted T-Cell Epitope of Escherichia coli Outer Membrane Protein F
Infect. Immun., July 1, 2004; 72(7): 3907 - 3913.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Y. Arnold, N. L. La Gruta, T. Miller, K. M. Vignali, P. S. Adams, D. L. Woodland, and D. A. A. Vignali
The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues
J. Immunol., July 15, 2002; 169(2): 739 - 749.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Sato, J. A. Zarutskie, M. M. Rushe, A. Lomakin, S. K. Natarajan, S. Sadegh-Nasseri, G. B. Benedek, and L. J. Stern
Determinants of the Peptide-induced Conformational Change in the Human Class II Major Histocompatibility Complex Protein HLA-DR1
J. Biol. Chem., January 21, 2000; 275(3): 2165 - 2173.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. B. Wilson, C. Pinilla, D. H. Wilson, K. Schroder, C. Boggiano, V. Judkowski, J. Kaye, B. Hemmer, R. Martin, and R. A. Houghten
Immunogenicity. I. Use of Peptide Libraries to Identify Epitopes That Activate Clonotypic CD4+ T Cells and Induce T Cell Responses to Native Peptide Ligands
J. Immunol., December 15, 1999; 163(12): 6424 - 6434.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. C. Harrison, M. C. Honeyman, S. Trembleau, S. Gregori, F. Gallazzi, P. Augstein, V. Brusic, J. Hammer, and L. Adorini
A Peptide-binding Motif for I-Ag7, the Class II Major Histocompatibility Complex (MHC) Molecule of NOD and Biozzi AB/H Mice
J. Exp. Med., March 17, 1997; 185(6): 1013 - 1022.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.